Schedule 13D ownership disclosure
ARGOS THERAPEUTICS INC
Security class unavailable · CUSIP: 040221103
Event date: 2016-11-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.4500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-067928
- Form type
- SC 13D
- Filer
- ARGOS THERAPEUTICS INC
- CIK
- CIK 1105533
- Filed
- Mar 02, 2017
- Reporting period
- Nov 09, 2016
- Description
- Schedule 13D beneficial ownership